{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:42:48Z","timestamp":1790775768183,"version":"4.1.0"},"reference-count":49,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:p>Background: Patients with spirochetal infection, which causes neurosyphilis (NS) and at a later stage general paresis of the insane (GPI), present with brain pathology features of Alzheimer\u2019s disease (AD). However, the relationships among these illnesses regarding biomarker levels are still unclear. Objective: To explore biomarker levels in NS and GPI compared with those in AD and the relationship between biomarker levels and cognitive function in NS and GPI. Methods: Levels of neurogranin (NGRN) and \u03b2-amyloid precursor protein cleaving enzyme (BACE1) in cerebrospinal fluid (CSF)\/plasma, together with amyloid-\u03b2 1\u201340 (A\u03b240), A\u03b242, and total tau in the CSF of 23 AD patients, 55 GPI patients, and 13 NS patients were measured. Patients were classified into none-to-mild, moderate, and severe stages of cognitive impairment. Results: Levels of CSF NGRN, BACE1, and tau as well as plasma BACE1 levels were significantly different among groups. In the none-to-mild stage, plasma BACE1 levels correlated with the protein levels in CSF and were significantly increased in AD patients versus GPI patients. The CSF tau levels in AD patients were significantly increased versus GPI patients in the moderate and severe stages. Pooling data from GPI and NS patients, both CSF tau and plasma NGRN levels correlated with cognitive scale scores. Conclusion: GPI and NS patients might have different biomarker level patterns compared to AD patients. While plasma BACE1 could be a promising early biomarker for distinguishing AD from GPI, CSF tau and plasma NGRN levels might be valuable in indications of cognitive function in pooled NS populations.<\/jats:p>","DOI":"10.3233\/jad-200362","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T16:38:17Z","timestamp":1597163897000},"page":"313-322","source":"Crossref","is-referenced-by-count":15,"title":["BACE1 and Other Alzheimer\u2019s-Related Biomarkers in Cerebrospinal Fluid and Plasma Distinguish Alzheimer\u2019s Disease Patients from Cognitively-Impaired Neurosyphilis Patients"],"prefix":"10.1177","volume":"77","author":[{"given":"Min","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Neurology, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Geriatric Psychiatry, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haishan","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Neurology, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugeen","family":"Vanmechelen","sequence":"additional","affiliation":[{"name":"ADx NeuroSciences NV, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"De Vos","sequence":"additional","affiliation":[{"name":"ADx NeuroSciences NV, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing Seven Dimension Neuroscience Research Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Geriatric Psychiatry, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naikeng","family":"Mai","sequence":"additional","affiliation":[{"name":"Department of Neurology, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Geriatric Psychiatry, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangying","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Geriatric Psychiatry, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Neurology, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huarong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurology, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Department of Geriatric Psychiatry, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiru","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Geriatric Psychiatry, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyuan","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Geriatric Psychiatry, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunying","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Geriatric Psychiatry, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Ning","sequence":"additional","affiliation":[{"name":"Department of Neurology, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China"},{"name":"The first School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China"},{"name":"Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-200362_ref1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2015.02.021","article-title":"Clinical and laboratory characteristics in patients suffering from general paresis in the modern era","volume":"350","author":"Chen","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-200362_ref2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neurobiolaging.2005.01.018","article-title":"Beta-amyloid deposition and Alzheimer\u2019s type changes induced by Borrelia spirochetes","volume":"27","author":"Miklossy","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-200362_ref3","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1093\/brain\/awx243","article-title":"Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease","volume":"140","author":"Bejanin","year":"2017","journal-title":"Brain"},{"key":"10.3233\/JAD-200362_ref4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol Sci"},{"key":"10.3233\/JAD-200362_ref5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(99)02355-7","article-title":"Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer\u2019s disease","volume":"354","author":"Esiri","year":"1999","journal-title":"Lancet"},{"key":"10.3233\/JAD-200362_ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2015.00046","article-title":"Historic evidence to support a causal relationship between spirochetal infections and Alzheimer\u2019s disease","volume":"7","author":"Miklossy","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-200362_ref7","first-page":"1","article-title":"Pathogenic microbes, the microbiome, and Alzheimer\u2019s disease (AD)","volume":"6","author":"Hill","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-200362_ref8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3233\/JAD-140621","article-title":"Bacterial infection and Alzheimer\u2019s disease: A meta-analysis","volume":"43","author":"Maheshwari","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-200362_ref9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s12035-012-8320-7","article-title":"Infectious agents and neurodegeneration","volume":"46","author":"De Chiara","year":"2012","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-200362_ref10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/eip.12441","article-title":"Medial temporal lobe atrophy as a predictor of poor cognitive outcomes in general paresis","volume":"13","author":"Chen","year":"2017","journal-title":"Early Interv Psychia"},{"key":"10.3233\/JAD-200362_ref11","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/ene.13074","article-title":"Syphilitic dementia and lipid metabolism","volume":"23","author":"Jiang","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-200362_ref12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1176\/appi.neuropsych.12.2.246","article-title":"Relationship between MRI findings and prognosis for patients with general paresis","volume":"12","author":"Kodama","year":"2000","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.3233\/JAD-200362_ref13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000326908","article-title":"Cognitive impairment in mild general paresis of the insane: AD-like pattern","volume":"31","author":"Wang","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-200362_ref14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200362_ref15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jalz.2007.08.006","article-title":"Core candidate neurochemical and imaging biomarkers of Alzheimer\u2019s disease","volume":"4","author":"Hampel","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200362_ref16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Update on hypothetical model of Alzheimer\u2019s disease biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-200362_ref17","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1093\/brain\/awv267","article-title":"Cerebrospinal fluid neurogranin: Relation to cognition and neurodegeneration in Alzheimer\u2019s disease","volume":"138","author":"Portelius","year":"2015","journal-title":"Brain"},{"key":"10.3233\/JAD-200362_ref18","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jalz.2015.05.012","article-title":"C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer\u2019s disease","volume":"11","author":"De Vos","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200362_ref19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2010.09.073","article-title":"Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer\u2019s disease","volume":"1362","author":"Thorsell","year":"2010","journal-title":"Brain Res"},{"key":"10.3233\/JAD-200362_ref20","doi-asserted-by":"crossref","first-page":"12787","DOI":"10.1523\/JNEUROSCI.3657-09.2009","article-title":"The \u03b2-secretase enzyme BACE in health and Alzheimer\u2019s disease: Regulation, cell biology, function, and therapeutic potential","volume":"29","author":"Vassar","year":"2009","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-200362_ref21","doi-asserted-by":"crossref","first-page":"12516","DOI":"10.1073\/pnas.1819541116","article-title":"NRF2\/ARE pathway negatively regulates BACE1 expression and ameliorates cognitive deficits in mouse Alzheimer\u2019s models","volume":"116","author":"Bahn","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-200362_ref22","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/archpsyc.64.6.718","article-title":"Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment","volume":"64","author":"Zhong","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JAD-200362_ref23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/ene.12680","article-title":"Different cerebrospinal fluid levels of Alzheimer-type biomarker A\u03b242 between general paresis and asymptomatic neurosyphilis","volume":"22","author":"Luo","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-200362_ref24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/01.olq.0000233738.23278.4e","article-title":"Cerebrospinal fluid tau protein is increased in neurosyphilis: A discrimination from syphilis without nervous system involvement?","volume":"34","author":"Paraskevas","year":"2007","journal-title":"Sex Transm Dis"},{"key":"10.3233\/JAD-200362_ref25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.3233\/JAD-200362_ref26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12888-016-0925-3","article-title":"Clinical and neuropsychological characteristics of general paresis misdiagnosed as primary psychiatric disease","volume":"16","author":"Yanhua","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.3233\/JAD-200362_ref27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-200362_ref28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-200362_ref29","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer\u2019s disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-200362_ref30","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3233\/JAD-160227","article-title":"The cerebrospinal fluid neurogranin\/BACE1 ratio is a potential correlate of cognitive decline in Alzheimer\u2019s disease","volume":"53","author":"De Vos","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-200362_ref31","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1373\/clinchem.2017.283028","article-title":"Neurogranin as cerebrospinal fluid biomarker for Alzheimer disease: An assay comparison study","volume":"64","author":"Willemse","year":"2018","journal-title":"Clin Chem"},{"key":"10.3233\/JAD-200362_ref32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000017111","article-title":"The progression of Alzheimer\u2019s disease from limbic regions to the neocortex: Clinical, radiological and pathological relationships","volume":"10","author":"Nagy","year":"1999","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-200362_ref33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000447056","article-title":"Impaired frontolimbic connectivity and depressive symptoms in patients with Alzheimer\u2019s disease","volume":"41","author":"Zhu","year":"2016","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-200362_ref34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/13554799708405011","article-title":"A neuropsychological and neuroimaging study of a patient before and after treatment for paretic neurosyphilis","volume":"3","author":"Mimura","year":"1997","journal-title":"Neurocase"},{"key":"10.3233\/JAD-200362_ref35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0006-3223(96)00060-1","article-title":"Psychiatric manifestations and magnetic resonance imaging in HIV-negative neurosyphilis","volume":"41","author":"Russouw","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-200362_ref36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/sextrans-2014-051961","article-title":"Susceptibility-weighted imaging in parenchymal neurosyphilis: Identification of a new MRI finding","volume":"91","author":"Pesaresi","year":"2015","journal-title":"Sex Transm Infect"},{"key":"10.3233\/JAD-200362_ref37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.biopsych.2017.02.007","article-title":"Increased plasma beta-secretase 1 may predict conversion to Alzheimer\u2019s disease dementia in individuals with mild cognitive impairment","volume":"83","author":"Shen","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-200362_ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2019.03.009","article-title":"Plasma amyloid \u03b2 40\/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer\u2019s disease","volume":"15","author":"Vergallo","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200362_ref39","first-page":"1","article-title":"The \u03b2-secretase BACE1 in Alzheimer\u2019s disease","volume":"20","author":"Hampel","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-200362_ref40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.15252\/emmm.201404438","article-title":"An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer\u2019s disease","volume":"7","author":"Yasuhiko","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-200362_ref41","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s00702-016-1597-3","article-title":"Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer\u2019s disease and in mild cognitive impairment due to AD","volume":"123","author":"Sanfilippo","year":"2016","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-200362_ref42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/1874205X01206010146","article-title":"Chronic or late lyme neuroborreliosis: Analysis of evidence compared to chronic or late neurosyphilis","volume":"6","author":"Miklossy","year":"2012","journal-title":"Open Neurol J"},{"key":"10.3233\/JAD-200362_ref43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.expneurol.2015.12.013","article-title":"Neurogranin restores amyloid \u03b2-mediated synaptic depression and long-term potentiation deficits","volume":"277","author":"Kaleka","year":"2015","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-200362_ref44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/mcp.M110.006353","article-title":"A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas","volume":"10","author":"Farrah","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"10.3233\/JAD-200362_ref45","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1182\/blood-2002-09-2797","article-title":"Transcript profiling of human platelets using microarray and serial analysis of gene expression","volume":"101","author":"Gnatenko","year":"2003","journal-title":"Blood"},{"key":"10.3233\/JAD-200362_ref46","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1186\/1471-2164-15-725","article-title":"A SAGE based approach to human glomerular endothelium: Defining the transcriptome, finding a novel molecule and highlighting endothelial diversity","volume":"15","author":"Sengoelge","year":"2014","journal-title":"BMC Genomics"},{"key":"10.3233\/JAD-200362_ref47","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1128\/MCB.23.13.4532-4541.2003","article-title":"Transcriptional program of apoptosis induction following interleukin 2 deprivation: Identification of RC3, a calcium\/calmodulin binding protein, as a novel proapoptotic factor","volume":"23","author":"Devireddy","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.3233\/JAD-200362_ref48","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.neurobiolaging.2007.08.019","article-title":"The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer\u2019s disease","volume":"30","author":"Glodzik-Sobanska","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-200362_ref49","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/clinchem\/47.10.1776","article-title":"Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: Establishment of reference values","volume":"47","author":"Sj\u00f6gren","year":"2001","journal-title":"Clin Chem"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-200362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:35Z","timestamp":1777370915000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-200362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":49,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-200362","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}